On this episode of The Pharmaverse Podcast, Art Krieg, the President of Zola Therapeutics, tells Michael that vision, endurance, resilience, and a whole lot of grit are needed to run a biotech.
Krieg has faced the rugged terrain and uphill climbs that come with building science-based companies. But just like a marathoner, he’s never stopped putting one foot in front of the other.
🎧 In this episode, Art and Michael discuss:
✅ The parallels between biotech leadership and long-distance running
✅ Lessons learned from exits, IPOs, and immuno-oncology breakthroughs
✅ Why perseverance and pacing are more important than ever in today’s market
𝐈𝐟 𝐲𝐨𝐮'𝐫𝐞 𝐚 𝐥𝐞𝐚𝐝𝐞𝐫 𝐨𝐫 𝐚𝐧 𝐚𝐬𝐩𝐢𝐫𝐢𝐧𝐠 𝐟𝐨𝐮𝐧𝐝𝐞𝐫—𝐭𝐡𝐢𝐬 𝐢𝐬 𝐚𝐧 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐲𝐨𝐮 𝐝𝐨𝐧’𝐭 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐦𝐢𝐬𝐬.
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD
E.M. Ray, L.A. Carey, K.E. Reeder-Hayes
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai